Mylan (MYL) Gains on Generic Concerta Approval
- Wall Street surges to new highs; transports set record
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Abbott (ABT) Files Complaint to Terminate Alere (ALR) Acquisition
- Costco Wholesale (COST) Tops Q1 EPS by 5c; Comps Up 1%, 2% Ex-Gas
- After-Hours Stock Movers 12/07: (VYGR) (LULU) (HRB( Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Mylan (NASDAQ: MYL) is active today after AB-rated approval on generic Concerta (methylphenidate hydrochloride) per the FDA website 10/21.
RBC analyst Randall Stanicky notes this approval follows last week’s announcement by FDA that it would pursue removal of BX-rated versions sold by MNK and LCI (Kudco) which would effectively leave TEVA alone in the market (acquired via AGN).
However, per the firm's back and forth with MYL today, it is unclear when the company will be able to launch as settlement terms with JNJ are undisclosed. Per JNJ's 10-k, it appears settlement was entered into around October 2015.
For TEVA (NASDQ: TEVA), they believe generic Concerta is ~$0.25 to EPS (4%) and an important product but one that we fully expect to see additional generic competition on and thus not a growth driver. TEVA may see some incremental upside for a short period of time given the potential for (we think likely) removal of BX competitors per FDA last week who collectively had ~15% share combined (TEVA ~78%) - 11% (MNK) and 4% (LCI) share.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mylan (MYL) Announces Restructuring Program; Sees Workforce Impact
- Credit Suisse Downgrades Murphy Oil Corp. (MUR) to Underperform
- Deutsche Bank Downgrades MGM Growth Properties (MGP) to Hold
Create E-mail Alert Related CategoriesAnalyst Comments, FDA, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!